Adrenocorticotropic Hormone (ACTH) for Post-op Inflammation in Proliferative Vitreoretinopathy (PVR)

Inclusion Criteria: * Age ≥ 18 years * Signed informed consent and authorization of use and disclosure of protected health information * Patients undergoing surgery for retinal detachment due to PVR Exclusion Criteria: * Patients with poorly controlled diabetes mellitus (defined as HbA1C ≥ 8.0% on any anti-diabetic medications or insulin. If the patient is using any anti-diabetic medication/insulin, he becomes eligible if the medication is used continuously for \>30 days) * Patients with poorly controlled hypertension (defined as systolic blood pressure \>180 mm Hg and/or diastolic blood pressure \>100 mm Hg at rest with up to 3 anti-hypertensive medications. If a patient's initial measurement exceeds these values, a second reading may be taken 30 or more mins later. If the patient is using any anti-hypertensives, he becomes eligible if the medication is used continuously for \>30 days) * Patients with congestive heart failure * Patients with scleroderma * Patients with osteoporosis * Patients with active systemic fungal infection * Patients with active ocular herpes simplex * Patients with prior or active bleeding peptic ulcer * Pregnant patients or patients who wish to become pregnant during the course of the study (females of child-bearing age will be counselled to use contraception for the duration of the study)